154 related articles for article (PubMed ID: 7569769)
1. Protective effects of calcium channel blockers on acute bromobenzene toxicity to isolated rat hepatocytes. Inhibition of phenylephrine-induced calcium oscillations.
Wu J; Danielsson A; Lindström P; Karlsson K; Sehlin J
Scand J Gastroenterol; 1995 Jun; 30(6):590-600. PubMed ID: 7569769
[TBL] [Abstract][Full Text] [Related]
2. Hepatotoxicity of ethanol: protective effect of calcium channel blockers in isolated hepatocytes.
Cobreros A; Sainz L; Lasheras B; Cenarruzabeitia E
Liver; 1997 Apr; 17(2):76-82. PubMed ID: 9138276
[TBL] [Abstract][Full Text] [Related]
3. Verapamil and diltiazem inhibit receptor-operated calcium channels and intracellular calcium oscillations in rat hepatocytes.
Striggow F; Bohnensack R
FEBS Lett; 1993 Mar; 318(3):341-4. PubMed ID: 8382636
[TBL] [Abstract][Full Text] [Related]
4. Nifedipine, verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium in MDCK cells.
Jan CR; Chen WC; Wu SN; Tseng CJ
Chin J Physiol; 1998 Dec; 41(4):181-8. PubMed ID: 10099864
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of trolox C, vitamin C, and catalase on bromobenzene-induced damage to rat hepatocytes.
Wu J; Karlsson K; Danielsson A
Scand J Gastroenterol; 1996 Aug; 31(8):797-803. PubMed ID: 8858750
[TBL] [Abstract][Full Text] [Related]
6. Anoxia/reoxygenation injury in hepatocytes is not prevented by calcium channel blockers.
Gasbarrini A; Borle AB; Caraceni P; Farghali H; Azzarone A; Fagiuoli S; Starzl TE; Van Thiel DH
Transplant Proc; 1992 Dec; 24(6):2812-3. PubMed ID: 1465950
[No Abstract] [Full Text] [Related]
7. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
Nègre-Salvayre A; Salvayre R
Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
[TBL] [Abstract][Full Text] [Related]
8. Effect of Ca2+ channel blockers, external Ca2+ and phospholipase A2 inhibitors on t-butylhydroperoxide-induced lipid peroxidation and toxicity in rat liver slices.
Heo J; Kim GH; Lee KS; Go WU; Ju HJ; Park SK; Song CS; Song GA; Cho M; Yang US; Moon HK; Kim YK
Korean J Intern Med; 1997 Jun; 12(2):193-200. PubMed ID: 9439155
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
Zhang WM; Wang HX; Xia Q; Wong TM
Br J Pharmacol; 1997 Mar; 120(5):827-32. PubMed ID: 9138688
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine-activated Ca(2+) permeability in newborn rat cortical collecting duct cells in primary culture.
Valencia L; Bidet M; Martial S; Sanchez E; Melendez E; Tauc M; Poujeol C; Martin D; Namorado MD; Reyes JL; Poujeol P
Am J Physiol Cell Physiol; 2001 May; 280(5):C1193-203. PubMed ID: 11287333
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine.
Grover GJ; Sleph PG
J Cardiovasc Pharmacol; 1989 Aug; 14(2):331-40. PubMed ID: 2476610
[TBL] [Abstract][Full Text] [Related]
12. Comparative effect of ursodeoxycholic acid and calcium antagonists on the binding, uptake and degradation of LDL in isolated hamster hepatocytes.
Bouscarel B; Ceryak S; Fromm H
Biochim Biophys Acta; 1996 Jun; 1301(3):230-6. PubMed ID: 8664333
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect on calcium channel blockers on alpha -adrenergic activation of glycogenolysis and calcium efflux in perfused rat liver.
Kimura S; Koide Y; Tada R; Abe K; Ogata E
Endocrinol Jpn; 1981 Feb; 28(1):69-78. PubMed ID: 7250070
[TBL] [Abstract][Full Text] [Related]
14. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
15. Improvement of the energy status of hypoxic hepatocytes by calcium channel blockers.
Brecht M; Brecht C; de Groot H
Res Commun Chem Pathol Pharmacol; 1993 Nov; 82(2):185-98. PubMed ID: 8303088
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of calcium channel blockers on thyroid hormone uptake in neonatal rat cardiomyocytes.
Verhoeven FA; Moerings EP; Lamers JM; Hennemann G; Visser TJ; Everts ME
Am J Physiol Heart Circ Physiol; 2001 Nov; 281(5):H1985-91. PubMed ID: 11668059
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of S-adenosyl-L-methionine on bromobenzene- and D-galactosamine-induced toxicity to isolated rat hepatocytes.
Wu J; Söderbergh H; Karlsson K; Danielsson A
Hepatology; 1996 Feb; 23(2):359-65. PubMed ID: 8591864
[TBL] [Abstract][Full Text] [Related]
18. Reversal of acute theophylline toxicity by calcium channel blockers in dogs and rats.
Whitehurst VE; Joseph X; Vick JA; Alleva FR; Zhang J; Balazs T
Toxicology; 1996 Jun; 110(1-3):113-21. PubMed ID: 8658552
[TBL] [Abstract][Full Text] [Related]
19. The porphyrogenic effects of calcium channel blocking drugs.
Schoenfeld N; Aelion J; Beigel Y; Epstein O; Atsmon A
Clin Sci (Lond); 1985 Nov; 69(5):581-6. PubMed ID: 4053511
[TBL] [Abstract][Full Text] [Related]
20. Effects of calcium channel blockers on neuromuscular blockade induced by aminoglycoside antibiotics.
Del Pozo E; Baeyens JM
Eur J Pharmacol; 1986 Aug; 128(1-2):49-54. PubMed ID: 3758187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
